Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
about
Population pharmacokinetics and pharmacodynamics of sitafloxacin in patients with community-acquired respiratory tract infections.Antibiotic Dosing in Patients With Acute Kidney Injury: "Enough But Not Too Much".A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii.Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.
P2860
Application of pharmacokinetics and pharmacodynamics to antimicrobial therapy of community-acquired respiratory tract infections.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Application of pharmacokinetic ...... respiratory tract infections.
@ast
Application of pharmacokinetic ...... respiratory tract infections.
@en
type
label
Application of pharmacokinetic ...... respiratory tract infections.
@ast
Application of pharmacokinetic ...... respiratory tract infections.
@en
prefLabel
Application of pharmacokinetic ...... respiratory tract infections.
@ast
Application of pharmacokinetic ...... respiratory tract infections.
@en
P2860
P356
P1433
P1476
Application of pharmacokinetic ...... respiratory tract infections.
@en
P2093
Esther Calbo
Javier Garau
P2860
P304
P356
10.1159/000089567
P577
2005-11-01T00:00:00Z